Revathy Pharma Pvt Ltd
About Revathy Pharma Pvt Ltd
Data last updated:
Revathy Pharma Pvt Ltd is a private limited company based in Kollam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1993PTC007245. Its GSTIN is 32AAACR9294A1ZK (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.89 Lakh. It is led by directors Biju Sreedharan Pillai (Managing Director) and Santhamma Govinda Pillai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Maruthamon Veedukanjirakode Kundara, Kollam, Kerala, India – 691501.
As per the financials filed for FY 2023, the company reported a revenue of ₹51.49 Lakh, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹10,886 (net margin 0.2%) and EBITDA of ₹6.61 Lakh (EBITDA margin 12.8%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹63.75 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressMaruthamon Veedukanjirakode Kundara, Kollam, Kerala, India – 691501
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Revathy Pharma Pvt Ltd
The main business activity of Revathy Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Revathy Pharma Pvt Ltd FY 2023 filings available
Revathy Pharma Pvt Ltd reported revenue of ₹51.49 Lakh (down 56% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Revathy Pharma Pvt Ltd
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 56% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Revathy Pharma Pvt Ltd
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10,886 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Revathy Pharma Pvt Ltd
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Revathy Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Revathy Pharma Pvt Ltd
Revathy Pharma Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royal Pharmaceuticals Industries Private Limited | ₹52.28 Lakh (FY 2025) | •••• | •••• | 284.0% | •••• | Mumbai, Maharashtra, India |
| Belmil Medical Centre Private Limited | ₹51.97 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Thrissur, Kerala, India |
| Indu Remedies Private Limited | ₹51.89 Lakh (FY 2020) | •••• | •••• | -38.0% | •••• | Chennai, Tamil Nadu, India |
| Montage Chemicals Private Limited | ₹51.87 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Thane, Maharashtra, India |
| Shri JB Pharma Private Limited | ₹51.63 Lakh (FY 2025) | •••• | •••• | 99.0% | •••• | Mumbai, Maharashtra, India |
| Revathy Pharma Pvt Ltd this company | ₹51.49 Lakh (FY 2023) | •••• | •••• | -56.0% | •••• | Kollam, Kerala, India |
| Bloom Remedies (India) Limited | ₹51.32 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | Udumalpet, Tamil Nadu, India |
| Donyi Polo Petrochemicals Limited | ₹51.31 Lakh (FY 2018) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Avakus India Private Limited | ₹51.2 Lakh (FY 2024) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Xithelia Nova Healthcare Private Limited | ₹51.16 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Kinetic Lifescience Private Limited | ₹51.14 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Jabalpur, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Revathy Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Revathy Pharma Pvt Ltd
Auditor information for Revathy Pharma Pvt Ltd provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Revathy Pharma Pvt Ltd
Revathy Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biju Sreedharan Pillai | Managing Director | 29 Apr 1997 | 29 Years 5 Months | Current |
| Santhamma Govinda Pillai | Director | 18 Jan 2002 | 24 Years 8 Months | Current |
Ownership and Shareholding of Revathy Pharma Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Revathy Pharma Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2021 | Canara Bank | ₹5 Lakh | Open |
| 24 Jun 2020 | Canara Bank | ₹9 Lakh | Open |
| 12 Oct 2010 | Canara Bank | ₹4.75 Lakh | Open |
| 04 Nov 1997 | Canara Bank | ₹45 Lakh | Open |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Revathy Pharma Pvt Ltd
Employment history and EPFO contributions of people linked to Revathy Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Revathy Pharma Pvt Ltd
Revathy Pharma Pvt Ltd has 2 board changes on record since 1997: 2 appointments. The latest: Santhamma Govinda Pillai was appointed as Director on 18 Jan 2002.
Credit Ratings, Litigation & Regulatory Alerts for Revathy Pharma Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Revathy Pharma Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Revathy Pharma Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Revathy Pharma Pvt Ltd
Revathy Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACR9294A1ZK | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Revathy Pharma Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revathy Pharma Pvt Ltd
Revathy Pharma is an active private limited company based in Kollam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 1993 (33+ years old) and is registered under CIN U24231KL1993PTC007245.
Revathy Pharma reported revenue of ₹51.49 Lakh for FY 2023 (down 56% YoY).
Revathy Pharma has 2 current directors:
- Biju Sreedharan Pillai - Managing Director
- Santhamma Govinda Pillai - Director
Revathy Pharma reported a net profit of ₹10,886 (net margin 0.2%) and EBITDA of ₹6.61 Lakh (EBITDA margin 12.8%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Revathy Pharma is -29% over three years and -19% over five years. In the latest year (FY 2023) revenue fell 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Revathy Pharma is 32AAACR9294A1ZK, registered in Kerala.
The CIN (Corporate Identification Number) of Revathy Pharma is U24231KL1993PTC007245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revathy Pharma was incorporated on 15 July 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Revathy Pharma by revenue are Royal Pharmaceuticals Industries Private Limited, Belmil Medical Centre Private Limited, Indu Remedies Private Limited, Montage Chemicals Private Limited, Shri JB Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Santhamma Govinda Pillai was appointed as Director on 18 Jan 2002. Biju Sreedharan Pillai was appointed as Managing Director on 29 Apr 1997.
The registered office of Revathy Pharma is at Maruthamon Veedukanjirakode Kundara, Kollam, Kerala, India – 691501.